Trial Profile
A Phase 1, Single Centre, Randomised, 2 Period Crossover Study to Determine the Effect of Food on the Pharmacokinetic Profile of a Single Dose of PBT2 Administered Orally to Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs PBT 2 (Primary)
- Indications Alzheimer's disease; Huntington's disease
- Focus Pharmacokinetics
- Sponsors Alterity Therapeutics
- 31 Jul 2014 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov record.
- 15 Apr 2014 New trial record